Series:

MIGS Unplugged

Helping guide you to make the right decision.

The Panama Canaloplasty

Show Description +

Arsham Sheybani, MD, and Iqbal Ike K. Ahmed, MD, take MIGS Unplugged on location to Panama. The duo invites Joseph F. Panarelli, MD, to discuss his experience performing ab interno canaloplasty with the iTrack microcatheter (Nova Eye Medical) and a heads-up 3D display. Dr. Panarelli highlights the importance of early intervention and treatment for patients with mild-to-moderate glaucoma and shares advice for surgeons who want to take a step forward in adopting new technology.

Posted: 8/30/2022

Up Next

The Role of MIGS in Angle Closure

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Manjool Shah, MD


Using MIGS to Expand Your Practice

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Michael D. Greenwood, MD; and Lorraine M. Provencher, MD

How to Grow Your Practice With MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Lorraine M. Provencher, MD; and Michael D. Greenwood, MD

Part Two: Matching the Best Glaucoma Procedure to Each Patient

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Davinder S. Grover, MD, MPH; and Mark J. Gallardo, MD

Matching the Best Glaucoma Procedure to Each Patient

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Davinder S. Grover, MD, MPH; and Mark J. Gallardo, MD

Traditional Glaucoma Surgery Meets MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Mary Qiu, MD

Sustained Drug Delivery: Expectations vs. Reality

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Nathan M. Radcliffe, MD

Successful Skills Transfer

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Bac T. Nguyen, MD

The Acceleration of Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; and Arsham Sheybani, MD

At-Home Diagnostics

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Barbara Wirostko, MD

MIGS in Multiples

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Xiongfei Liu, MD

The Case for Standalone MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Ahmed vs. Sheybani: Round 3

Iqbal Ike K. Ahmed, MD, FRCSC; and Arsham Sheybani, MD

Ahmed vs. Sheybani: Round 2

Iqbal Ike K. Ahmed, MD, FRCSC; and Arsham Sheybani, MD

Ahmed vs. Sheybani: Round 1

Iqbal Ike K. Ahmed, MD, FRCSC; and Arsham Sheybani, MD

MIGS Developments Anticipated in 2021

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Sahar Bedrood, MD, PhD; Monisha M. Vora, MD; Michael D. Greenwood, MD; Lorraine M. Provencher, MD; and Larissa Camejo, MD

A Newer Device on the MIGS Scene

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Matt Schlenker, MD

Clearing Hurdles in MIGS Care

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Oluwatosin Smith, MD

MIGS and Match: Combining Procedures for Optimal Effect

Arsham Sheybani, MD, I. Paul Singh, MD, Ike K. Ahmed MD

One Piece of a Complex Puzzle

Arsham Sheybani, MD, Iqbal (Ike) K. Ahmed, MD, Peter Chang, MD

Showcasing Two Surgical Techniques

Anna T. Do, MD, Arsham Sheybani, MD, Brian Francis, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Insights Into a Canal-Based MIGS Procedure

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Thomas Samuelson, MD

More Options in Glaucoma Drainage Devices

Arsham Sheybani, MD, Ian Conner, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Leonard Seibold, MD

Separating the IOP-Lowering Effects of MIGS and Cataract Surgery

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Jason Bacharach, MD

Educating the Next Generation of Surgeons

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Kelly Muir, MD

Advice on Learning to Perform MIGS Procedures

Iqbal Ike K. Ahmed, MD, FRCSC, Jeb A. Ong, MD, Valentina Lozano, MD

Optimizing the Use of an Antifibrotic Agent

Arsham Sheybani, MD, Richard Schroeder, MD

Learning to Use a Second-Generation Trabecular Microbypass System

Iqbal Ike K. Ahmed, MD, FRCSC, Jeb A. Ong, MD, Valentina Lozano, MD

Getting Started With Angle Surgery

Arsham Sheybani, MD, Richard Schroeder, MD

An Alternative Device for Patients With Moderate Glaucoma

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Joseph F. Panarelli, MD

Fresh Insights Into Scaffolding Schlemm Canal

Arsham Sheybani, MD, Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Canal Surgery for Glaucoma

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Steven R. Sarkisian, Jr., MD

The Angle's Importance in MIGS

Arsham Sheybani, MD, Ian Conner, MD, Iqbal Ike K. Ahmed, MD, FRCSC

The Roles of Advanced Imaging and Gonioscopy

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Lauren S. Blieden, MD

Patient Selection for a Subconjunctival MIGS Device

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Manjool Shah, MD

Choosing Among MIGS Procedures

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Oluwatosin U. Smith, MD

Tips for Success With a Second-Generation MIGS Device

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Sahar Bedrood, MD, PhD

How to Expand Schlemm Canal Successfully

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Managing Patients Who Received a Supraciliary Microstent

Jacob Brubaker, MD, Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Accessing the Power of the Subconjunctival Space

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Scaffolding Schlemm Canal for Mild Glaucoma

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

The Latest Canal-Based MIGS Option

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Surgical Options for Pseudophakic Patients With Glaucoma

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Nathan Radcliffe, MD

MIGS for a Uveitic Patient on Maximum-Tolerated IOP-Lowering Medical Therapy

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Rejuvenating the Outflow System After Failed Trabeculectomy

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Deciding on an Appropriate MIGS Procedure

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Nathan Radcliffe, MD

Ensuring Proper iStent Placement

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Introducing: MIGS Unplugged

Arsham Sheybani, MD, I. Paul Singh, MD, Iqbal (Ike) K. Ahmed, MD, Nathan Radcliffe, MD

Science and Pathophysiology of MIGS Procedures

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Douglas J. Rhee, MD

Excimer Laser Trabeculostomy

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Cathleen M. McCabe, MD

MIGS Unplugged LIVE: Rethinking Early Intervention in Glaucoma Care

Arsham Sheybani, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Brian M. Shafer, MD; and Christine M. Funke, MD

Glaucoma Intervention in the Supraciliary Space

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Kristin O. Bretz, MD

The Role of Viscodilation in Glaucoma Surgery

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Leonard K. Seibold, MD

Ab Externo Xen Gel Stent Implantation

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Oluwatosin U. Smith, MD

Interventional Valve-Enhancing Trabeculotomy

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Davinder S. Grover, MD, MPH

Insights and Pearls for Preserflo

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Keith Barton, MD, FRCP, FRCS

Supraciliary MIGS With MINIject

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Kaweh Mansouri, MD, MPH

Implantation Pearls and Data Discussion for Hydrus Microstent

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Nishani Amerasinghe, MB, BS, BSc, FRCOphth

Viscodilation in the Canal

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Karl Mercieca, MRCOphth, FRCOphth, PGCM(Ed), FEBOS-GL

Streamlining Glaucoma Procedures

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Ariana Levin, MD

IOL Selection in Combination MIGS Procedures

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Deborah Ristvedt, DO

MIGS in Private Practice

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Emily Schehlein, MD

Reflections on the Reimbursement Landscape

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Nathan M. Radcliffe, MD

Micropulse Laser Therapy

Ike Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Larissa Camejo, MD

Experience With the TrabEx Pro

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Lorraine M. Provencher, MD

Suprachoroidal MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Antonio Fea, MD, PhD

The Role of MIGS in Pediatric Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Zeynep Aktas, MD, FEBO

Genetics in Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Janey L. Wiggs, MD, PhD

SLT as First-Line Therapy

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Management of Angle-Closure Glaucoma

Ike Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Clement CY Tham, BM BCh (Oxon), FCOphthHK, FHKAM (Ophth), FRCOphth, FRCS (Glas), FCSHK

MIGS in the Suprachoroidal Space

Ike Ahmed, MD, FRCSC; and Arsham Sheybani, MD

Goniotomy: Surgical Pearls and Considerations

Ike Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Matthew Brink, MD

Success With Intracameral Drug Delivery

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and I. Paul Singh, MD

Comparative Study of Endothelial Cell Loss

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Ticiana De Francesco, MD

Training in MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Paul Chamberlain, MD; and Shawn Gulati, MD, MPH

MIGS Research and Outcomes

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Ticiana De Francesco, MD

MIGS in the Developing World

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Craig J. Chaya, MD

Viscodilation in the Canal

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Real-World MIGS Safety

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sarah Van Tassel, MD

Part Two: Important Considerations From GPS Trial Data

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD

Outcomes and Highlights of the GPS Trial

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD

Canaloplasty and Viscodilation in MIGS

Iqbal Ike K. Ahmed, MD, FRCSC; and Arsham Sheybani, MD

The Panama Canaloplasty

Arsham Sheybani, MD, and Iqbal Ike K. Ahmed, MD, take MIGS Unplugged on location to Panama. The duo invites Joseph F. Panarelli, MD, to discuss his experience performing ab interno canaloplasty with the iTrack microcatheter (Nova Eye Medical) and a heads-up 3D display. Dr. Panarelli highlights the importance of early intervention and treatment for patients with mild-to-moderate glaucoma and shares advice for surgeons who want to take a step forward in adopting new technology.

Posted: 8/30/2022

Read Transcript

00:00:00.102 --> 00:00:03.185
(upbeat funky music)

00:00:08.340 --> 00:00:09.810
Welcome to MIGS Unplugged.

00:00:09.810 --> 00:00:12.450
Here we are onsite in Panama.

00:00:12.450 --> 00:00:15.150
Joe Panarelli here with Ike Ahmed.

00:00:15.150 --> 00:00:16.110
I'm Arsham Sheybani.

00:00:16.110 --> 00:00:18.930
And you know, Joe finally got to experience what

00:00:18.930 --> 00:00:21.960
it's like to be Ike's fellow for a case.

00:00:21.960 --> 00:00:22.793
I did.

00:00:22.793 --> 00:00:24.660
I got to tell you that the juices were flowing.

00:00:24.660 --> 00:00:27.060
I was trying to control the nerves.

00:00:27.060 --> 00:00:29.580
I was hoping that I had taken my morning dose

00:00:29.580 --> 00:00:32.610
of a beta blocker or something to control the anxiety,

00:00:32.610 --> 00:00:35.010
but it was a blast and I could see why so many

00:00:35.010 --> 00:00:36.930
go to work with the legend.

00:00:36.930 --> 00:00:37.763
It was really a fun time.

00:00:37.763 --> 00:00:38.785
It was fantastic.

00:00:38.785 --> 00:00:39.780
And Joe, we've talked about this.

00:00:39.780 --> 00:00:41.850
We don't do a lot of angle surgery.

00:00:41.850 --> 00:00:43.080
The population's a little bit different.

00:00:43.080 --> 00:00:44.430
A lot of times people have already worked in

00:00:44.430 --> 00:00:45.690
the angle before.

00:00:45.690 --> 00:00:48.243
How was it for you and maybe just kind of tell us,

00:00:49.320 --> 00:00:50.700
we just did ab interno canaloplasty

00:00:50.700 --> 00:00:53.250
with the new iTrack catheter.

00:00:53.250 --> 00:00:54.450
It's a 3D heads-up display.

00:00:54.450 --> 00:00:56.070
I think it's a tough question for all of us.

00:00:56.070 --> 00:00:57.640
We're always trying to figure out,

00:00:57.640 --> 00:01:00.030
when are we comfortable to take that next step

00:01:00.030 --> 00:01:01.230
to push the envelope?

00:01:01.230 --> 00:01:03.360
And I think that's what makes us better.

00:01:03.360 --> 00:01:04.680
It's what makes all of us better.

00:01:04.680 --> 00:01:05.550
We would all tell you that.

00:01:05.550 --> 00:01:07.440
We don't want to tackle too many things at once,

00:01:07.440 --> 00:01:09.870
but for me personally, I got really comfortable

00:01:09.870 --> 00:01:12.720
doing more traditional glaucoma surgery early in my career,

00:01:12.720 --> 00:01:14.400
tried to really perfect my trabeculectomy

00:01:14.400 --> 00:01:15.570
and tube shunt skills.

00:01:15.570 --> 00:01:17.070
I did a good amount of angle surgery,

00:01:17.070 --> 00:01:20.340
not nearly as much as you guys, but it was really nice.

00:01:20.340 --> 00:01:21.540
One of the reasons I wanted to come down here

00:01:21.540 --> 00:01:23.520
was really to sort of learn from the best

00:01:23.520 --> 00:01:24.780
and really kind of get back into it

00:01:24.780 --> 00:01:27.870
because you hear more and more about how this approach

00:01:27.870 --> 00:01:30.060
probably really is beneficial for some of our patients

00:01:30.060 --> 00:01:32.720
who have more mild disease and how we need to treat

00:01:32.720 --> 00:01:34.530
a little more aggressively early on,

00:01:34.530 --> 00:01:36.360
and you want to have the proper tools to do this.

00:01:36.360 --> 00:01:40.950
So for me, canaloplasty makes sense and it was really nice

00:01:40.950 --> 00:01:42.900
to get to have this experience today.

00:01:42.900 --> 00:01:45.960
So Joe, so much of our focus in glaucoma surgery

00:01:45.960 --> 00:01:48.060
is the devices and instrumentation,

00:01:48.060 --> 00:01:49.110
but I think sometimes

00:01:49.110 --> 00:01:50.460
I forget visualization.
Yeah.

00:01:50.460 --> 00:01:51.293
Right, the setting up.

00:01:51.293 --> 00:01:55.755
So, you literally were not going to do 3D surgery today.

00:01:55.755 --> 00:01:56.588
And in fact-

00:01:56.588 --> 00:01:57.421
I had no plan.

00:01:57.421 --> 00:01:59.880
I had never watched 3D surgery.

00:01:59.880 --> 00:02:00.720
Exactly.

00:02:00.720 --> 00:02:01.974
And in fact you were-

00:02:01.974 --> 00:02:02.910
In fact when they would turn it on in the OR,

00:02:02.910 --> 00:02:04.170
I would be like, "I'm out of here."

00:02:04.170 --> 00:02:05.460
Yeah.

00:02:05.460 --> 00:02:06.420
And in fact, many times you're about to, not,

00:02:06.420 --> 00:02:07.590
you're backing away, right?

00:02:07.590 --> 00:02:08.550
But you jumped in there and did it,

00:02:08.550 --> 00:02:11.760
so what advances do you see, whether it's 3D

00:02:11.760 --> 00:02:13.860
or something else, that you may think allow us

00:02:13.860 --> 00:02:17.160
to harness the power of what MIGS can do?

00:02:17.160 --> 00:02:20.400
I think definitely the visualization is key.

00:02:20.400 --> 00:02:22.950
I think when you're talking about any sort of surgery

00:02:22.950 --> 00:02:24.750
in the angle, you want to really have,

00:02:24.750 --> 00:02:25.830
you want to be comfortable.

00:02:25.830 --> 00:02:27.420
Your posture, you want to be comfortable

00:02:27.420 --> 00:02:28.530
with what you're looking at.

00:02:28.530 --> 00:02:31.410
And I will say this, even though it was my first experience

00:02:31.410 --> 00:02:33.690
with a decent-sized crowd in the room,

00:02:33.690 --> 00:02:37.230
I felt pretty comfortable, which I totally did not expect.

00:02:37.230 --> 00:02:39.360
And I'd say it's amazing how it started,

00:02:39.360 --> 00:02:42.090
and 10 minutes later when we started doing

00:02:42.090 --> 00:02:44.970
additional surgery, I really, I felt even more comfortable.

00:02:44.970 --> 00:02:48.180
So, I think it's true that we want to work

00:02:48.180 --> 00:02:49.890
outside of our comfort zone at times

00:02:49.890 --> 00:02:51.660
while making sure we have good backup.

00:02:51.660 --> 00:02:52.980
I think that's always one of the things,

00:02:52.980 --> 00:02:55.080
it's my teaching point to all my trainees,

00:02:55.080 --> 00:02:58.590
go ahead, push yourself, but make sure that you have

00:02:58.590 --> 00:03:00.150
the proper support, because we always want to do

00:03:00.150 --> 00:03:01.449
what's best for the patient and-

00:03:01.449 --> 00:03:02.282
What was your backup?

00:03:02.282 --> 00:03:03.115
I had you there, man.

00:03:03.115 --> 00:03:06.557
I had you, I had like the top 10 surgeons in the world.

00:03:06.557 --> 00:03:07.858
I felt like I could do anything.

00:03:07.858 --> 00:03:08.700
Was he scrubbed in then?

00:03:08.700 --> 00:03:10.530
I don't, he might have been scrubbed in.

00:03:10.530 --> 00:03:12.960
All I know is there was some taunting going on as well,

00:03:12.960 --> 00:03:14.280
which made it a little bit tricky.

00:03:14.280 --> 00:03:17.310
Now, but this does play into many surgeons out there

00:03:17.310 --> 00:03:19.170
who are watching MIGS and they're not sure whether

00:03:19.170 --> 00:03:20.190
to jump in or not.

00:03:20.190 --> 00:03:21.900
And maybe they don't have a mentor

00:03:21.900 --> 00:03:23.040
or have someone with them in there.

00:03:23.040 --> 00:03:25.740
So, how do people make that step forward?

00:03:25.740 --> 00:03:27.518
Whether it's innovation or whether it's just adopting

00:03:27.518 --> 00:03:30.030
new ideas, new technologies?

00:03:30.030 --> 00:03:31.778
I think it's, educate yourself.

00:03:31.778 --> 00:03:34.560
Read the literature, read the right literature.

00:03:34.560 --> 00:03:37.500
I think unfortunately there's a lot of literature out there

00:03:37.500 --> 00:03:39.960
and you have published some reports on this about

00:03:39.960 --> 00:03:42.210
how we really want the best and the highest forms

00:03:42.210 --> 00:03:45.270
of data to support the use of a lot of these devices.

00:03:45.270 --> 00:03:46.103
And it's out there.

00:03:46.103 --> 00:03:47.820
And more is being poured into the community.

00:03:47.820 --> 00:03:50.730
But I think understanding what you should expect to get

00:03:50.730 --> 00:03:53.460
from these procedures, choosing the right patients,

00:03:53.460 --> 00:03:55.410
and then accepting that you're going to have some failure

00:03:55.410 --> 00:03:56.880
early on, and that's okay.

00:03:56.880 --> 00:03:58.260
We're all, none of us are going to be,

00:03:58.260 --> 00:04:01.650
I think the thinking is, when we do these surgeries,

00:04:01.650 --> 00:04:03.150
we never experience any failure.

00:04:03.150 --> 00:04:04.320
Patients end up perfect.

00:04:04.320 --> 00:04:07.830
And I think we all do our best to improve our success rates,

00:04:07.830 --> 00:04:10.260
but man, we all go through our ups and downs.

00:04:10.260 --> 00:04:12.990
And so I think that's a big point that I try to stress

00:04:12.990 --> 00:04:15.267
to anybody who's adopting it for the first time.

00:04:15.267 --> 00:04:17.010
You're going to have some bumps in the road,

00:04:17.010 --> 00:04:19.110
but keep at it, keep at it.

00:04:19.110 --> 00:04:20.940
If there were other devices that I used that I gave

00:04:20.940 --> 00:04:24.300
up early on, it would've been, I'd feel ashamed,

00:04:24.300 --> 00:04:26.310
because at this point I try to utilize all these tools.

00:04:26.310 --> 00:04:28.500
Well, speaking of, before we start to wrap up,

00:04:28.500 --> 00:04:29.993
you're a big ab externo canaloplasty guy.

00:04:31.860 --> 00:04:32.693
Yeah, yeah.

00:04:32.693 --> 00:04:33.929
How was your experience doing that?

00:04:33.929 --> 00:04:34.762
Yeah, it was very nice.

00:04:34.762 --> 00:04:37.500
As a pediatric glaucoma specialist, I definitely work

00:04:37.500 --> 00:04:38.970
a little more from an external approach

00:04:38.970 --> 00:04:41.310
because a lot of times the children don't,

00:04:41.310 --> 00:04:43.560
there's not great visualization, but I will tell you,

00:04:43.560 --> 00:04:47.340
the comfort with that hand piece and the ability,

00:04:47.340 --> 00:04:48.450
even with the system you're using today,

00:04:48.450 --> 00:04:50.700
to have such good visualization, I would definitely think

00:04:50.700 --> 00:04:52.140
about maybe making the switch

00:04:52.140 --> 00:04:53.760
and maybe doing some more ab interno surgery.

00:04:53.760 --> 00:04:55.800
And I think sometimes you do, you just need that kick.

00:04:55.800 --> 00:04:57.590
I got that kick today.

00:04:57.590 --> 00:04:58.620
But it's great.

00:04:58.620 --> 00:05:00.720
It's really a pleasure getting to work with everybody here.

00:05:00.720 --> 00:05:03.060
And it's an honor.

00:05:03.060 --> 00:05:05.310
Well, it was amazing to work with new innovation

00:05:05.310 --> 00:05:07.410
and MIGS new visualization from surgeons

00:05:07.410 --> 00:05:08.243
that haven't used it before.

00:05:08.243 --> 00:05:09.330
Who just, by the way, he kicked butt.

00:05:09.330 --> 00:05:10.163
He was fantastic.

00:05:10.163 --> 00:05:11.310
It was fantastic, it was.

00:05:11.310 --> 00:05:12.480
And the cataract, too.

00:05:12.480 --> 00:05:13.890
And the cataract, yeah, I wasn't expecting that.

00:05:13.890 --> 00:05:15.780
That was a little treat, a little added bonus.

00:05:15.780 --> 00:05:16.613
So something that-

00:05:17.670 --> 00:05:19.008
Something, got to push yourself a little bit.

00:05:19.008 --> 00:05:21.450
I think it's great to see innovations we see now

00:05:21.450 --> 00:05:23.490
in canaloplasty making this more accessible

00:05:23.490 --> 00:05:24.690
and advancing the technology.

00:05:24.690 --> 00:05:27.510
So thank you, Arsham, thank you, Joe for being part of this.

00:05:27.510 --> 00:05:29.010
This is another edition of MIGS Unplugged.

00:05:29.010 --> 00:05:30.723
Stay tuned for our next version.

Please log in to leave a comment.